SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5zov'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EI6_C_PPFC413_1 (PHOSPHONOACETATE HYDROLASE)	5zov	- (-)	4 / 8	ASP A 314 HIS A 194 HIS A 135 ILE A 358	ASC A 501 (-2.7A) ASC A 501 (-4.0A) ASC A 501 (-4.0A) ASC A 501 ( 4.9A)	0.98A	1ei6C-5zovA: undetectable	1ei6C-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QKN_A_RALA600_1 (ESTROGEN RECEPTOR BETA)	5zov	- (-)	6 / 12	LEU A 165 THR A 162 ALA A 163 LEU A 114 ILE A 172 GLY A 171	None	1.44A	1qknA-5zovA: undetectable	1qknA-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WRL_A_TFPA204_1 (TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES)	5zov	- (-)	4 / 7	LEU A 62 PHE A 244 MET A 240 MET A 360	None	0.99A	1wrlA-5zovA: undetectable 1wrlB-5zovA: undetectable	1wrlA-5zovA: undetectable 1wrlB-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HMA_A_SAMA375_0 (PROBABLE TRNA (5-METHYLAMINOMETHYL -2-THIOURIDYLATE)-ME THYLTRANSFERASE)	5zov	- (-)	5 / 11	SER A 295 THR A 133 GLY A 134 HIS A 135 GLN A 139	None None None ASC A 501 (-4.0A) ASC A 501 (-3.1A)	1.45A	2hmaA-5zovA: undetectable	2hmaA-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WSC_A_PQNA1802_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1)	5zov	- (-)	5 / 9	PHE A 347 SER A 349 ALA A 340 LEU A 343 GLY A 346	None	1.07A	2wscA-5zovA: 3.6	2wscA-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WSE_A_PQNA1801_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1)	5zov	- (-)	5 / 9	PHE A 347 SER A 349 ALA A 340 LEU A 343 GLY A 346	None	1.06A	2wseA-5zovA: 2.6	2wseA-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WSF_A_PQNA1802_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1)	5zov	- (-)	5 / 9	PHE A 347 SER A 349 ALA A 340 LEU A 343 GLY A 346	None	1.07A	2wsfA-5zovA: 2.2	2wsfA-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X2N_A_X2NA1480_1 (LANOSTEROL 14-ALPHA-DEMETHYLASE)	5zov	- (-)	5 / 12	PHE A 370 PRO A 180 ALA A 183 ALA A 416 MET A 177	None	1.26A	2x2nA-5zovA: undetectable	2x2nA-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X2N_B_X2NB1479_1 (LANOSTEROL 14-ALPHA-DEMETHYLASE)	5zov	- (-)	5 / 12	PHE A 370 PRO A 180 ALA A 183 ALA A 416 MET A 177	None	1.27A	2x2nB-5zovA: undetectable	2x2nB-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X2N_C_X2NC1479_1 (LANOSTEROL 14-ALPHA-DEMETHYLASE)	5zov	- (-)	5 / 12	PHE A 370 PRO A 180 VAL A 184 ALA A 416 MET A 177	None	1.35A	2x2nC-5zovA: undetectable	2x2nC-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_E_TFPE201_1 (PROTEIN S100-A4)	5zov	- (-)	5 / 7	PHE A 52 GLY A 51 PHE A 290 MET A 90 PHE A 138	None	1.34A	3ko0D-5zovA: undetectable 3ko0E-5zovA: 0.8	3ko0D-5zovA: undetectable 3ko0E-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LW5_A_PQNA5001_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1)	5zov	- (-)	5 / 9	PHE A 347 SER A 349 ALA A 340 LEU A 343 GLY A 346	None	1.08A	3lw5A-5zovA: 3.5	3lw5A-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DJF_B_C2FB300_0 (5-METHYLTETRAHYDROFO LATE CORRINOID/IRON SULFUR PROTEIN METHYLTRANSFERASE)	5zov	- (-)	5 / 12	PHE A 147 ILE A 353 LEU A 344 GLY A 394 GLN A 427	None	1.45A	4djfB-5zovA: undetectable	4djfB-5zovA: 18.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EM2_A_SALA504_1 (UNCHARACTERIZED HTH-TYPE TRANSCRIPTIONAL REGULATOR SAR2349)	5zov	- (-)	4 / 8	GLY A 356 ILE A 358 ILE A 280 THR A 88	None ASC A 501 ( 4.9A) None None	0.48A	4em2A-5zovA: undetectable	4em2A-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JX1_F_CAMF502_0 (CAMPHOR 5-MONOOXYGENASE)	5zov	- (-)	4 / 4	TYR A 87 THR A 285 VAL A 55 ILE A 280	ASC A 501 (-4.0A) None None None	1.08A	4jx1F-5zovA: undetectable	4jx1F-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LNW_A_T3A502_1 (THYROID HORMONE RECEPTOR ALPHA)	5zov	- (-)	4 / 8	GLU A 391 GLN A 337 VAL A 239 THR A 236	None	0.88A	4lnwA-5zovA: undetectable	4lnwA-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LNX_A_T44A501_1 (THYROID HORMONE RECEPTOR ALPHA)	5zov	- (-)	4 / 6	GLU A 391 GLN A 337 VAL A 239 THR A 236	None	0.98A	4lnxA-5zovA: undetectable	4lnxA-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	4qvmV-5zovA: undetectable 4qvmb-5zovA: undetectable	4qvmV-5zovA: undetectable 4qvmb-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	4qvmH-5zovA: undetectable 4qvmN-5zovA: undetectable	4qvmH-5zovA: undetectable 4qvmN-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 12	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	4qvnV-5zovA: undetectable 4qvnb-5zovA: undetectable	4qvnV-5zovA: undetectable 4qvnb-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 12	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	4qvnH-5zovA: undetectable 4qvnN-5zovA: undetectable	4qvnH-5zovA: undetectable 4qvnN-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	4qvpV-5zovA: undetectable 4qvpb-5zovA: undetectable	4qvpV-5zovA: undetectable 4qvpb-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.24A	4qvpH-5zovA: undetectable 4qvpN-5zovA: undetectable	4qvpH-5zovA: undetectable 4qvpN-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	4qvqV-5zovA: undetectable 4qvqb-5zovA: undetectable	4qvqV-5zovA: undetectable 4qvqb-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	4qvqH-5zovA: undetectable 4qvqN-5zovA: undetectable	4qvqH-5zovA: undetectable 4qvqN-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	4qw0V-5zovA: undetectable 4qw0b-5zovA: undetectable	4qw0V-5zovA: undetectable 4qw0b-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	4qw0H-5zovA: undetectable 4qw0N-5zovA: undetectable	4qw0H-5zovA: undetectable 4qw0N-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	4qw3V-5zovA: undetectable 4qw3b-5zovA: undetectable	4qw3V-5zovA: undetectable 4qw3b-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	4qw3H-5zovA: undetectable 4qw3N-5zovA: undetectable	4qw3H-5zovA: undetectable 4qw3N-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RP8_A_ASCA501_0 (ASCORBATE-SPECIFIC PERMEASE IIC COMPONENT ULAA)	5zov	- (-)	10 / 11	TYR A 87 HIS A 135 ILE A 136 GLN A 139 HIS A 194 GLN A 195 ASP A 314 ALA A 316 PHE A 362 MET A 415	ASC A 501 (-4.0A) ASC A 501 (-4.0A) None ASC A 501 (-3.1A) ASC A 501 (-4.0A) ASC A 501 (-4.2A) ASC A 501 (-2.7A) ASC A 501 (-3.6A) ASC A 501 (-3.8A) ASC A 501 ( 4.6A)	0.32A	4rp8A-5zovA: 44.5	4rp8A-5zovA: undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RP8_C_ASCC501_0 (ASCORBATE-SPECIFIC PERMEASE IIC COMPONENT ULAA)	5zov	- (-)	9 / 12	HIS A 135 ILE A 136 GLN A 139 HIS A 194 GLN A 195 ALA A 316 ILE A 358 PHE A 362 MET A 415	ASC A 501 (-4.0A) None ASC A 501 (-3.1A) ASC A 501 (-4.0A) ASC A 501 (-4.2A) ASC A 501 (-3.6A) ASC A 501 ( 4.9A) ASC A 501 (-3.8A) ASC A 501 ( 4.6A)	0.35A	4rp8C-5zovA: 44.7	4rp8C-5zovA: 62.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RP9_A_ASCA501_0 (ASCORBATE-SPECIFIC PERMEASE IIC COMPONENT ULAA)	5zov	- (-)	11 / 12	TYR A 87 HIS A 135 ILE A 136 GLN A 139 GLN A 195 ASP A 314 CYH A 315 ALA A 316 ILE A 358 PHE A 362 MET A 415	ASC A 501 (-4.0A) ASC A 501 (-4.0A) None ASC A 501 (-3.1A) ASC A 501 (-4.2A) ASC A 501 (-2.7A) ASC A 501 ( 4.3A) ASC A 501 (-3.6A) ASC A 501 ( 4.9A) ASC A 501 (-3.8A) ASC A 501 ( 4.6A)	0.35A	4rp9A-5zovA: 40.9	4rp9A-5zovA: 62.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	5cz7H-5zovA: undetectable 5cz7N-5zovA: undetectable	5cz7H-5zovA: undetectable 5cz7N-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	5d0xV-5zovA: undetectable 5d0xb-5zovA: undetectable	5d0xV-5zovA: undetectable 5d0xb-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	5d0xH-5zovA: undetectable 5d0xN-5zovA: undetectable	5d0xH-5zovA: undetectable 5d0xN-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IK1_A_CAMA502_0 (CAMPHOR 5-MONOOXYGENASE)	5zov	- (-)	4 / 5	PHE A 385 LEU A 343 GLY A 342 ILE A 335	None	0.91A	5ik1A-5zovA: undetectable	5ik1A-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 12	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	5l5zV-5zovA: undetectable 5l5zb-5zovA: undetectable	5l5zV-5zovA: undetectable 5l5zb-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 12	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	5l5zH-5zovA: undetectable 5l5zN-5zovA: undetectable	5l5zH-5zovA: undetectable 5l5zN-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	5l66V-5zovA: undetectable 5l66b-5zovA: undetectable	5l66V-5zovA: undetectable 5l66b-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5zov	- (-)	5 / 11	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	5l66H-5zovA: undetectable 5l66N-5zovA: undetectable	5l66H-5zovA: undetectable 5l66N-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF3_B_BO2B305_1 (PROTEASOME SUBUNIT BETA TYPE-6)	5zov	- (-)	5 / 12	THR A 408 THR A 407 GLY A 411 ALA A 92 THR A 88	None	1.25A	5lf3b-5zovA: undetectable	5lf3b-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NFP_A_8W5A804_2 (GLUCOCORTICOID RECEPTOR)	5zov	- (-)	4 / 4	LEU A 442 MET A 447 ILE A 425 LEU A 168	None	1.39A	5nfpA-5zovA: undetectable	5nfpA-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OG9_A_TESA504_1 (-)	5zov	- (-)	5 / 8	ILE A 84 VAL A 398 THR A 96 ALA A 92 THR A 93	None	1.32A	5og9A-5zovA: 2.5	5og9A-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U6M_A_SALA503_1 (UDP-GLYCOSYLTRANSFER ASE 74F2)	5zov	- (-)	4 / 7	HIS A 194 GLN A 196 MET A 413 MET A 131	ASC A 501 (-4.0A) None None None	1.47A	5u6mA-5zovA: undetectable	5u6mA-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U6M_B_SALB503_1 (UDP-GLYCOSYLTRANSFER ASE 74F2)	5zov	- (-)	4 / 7	HIS A 194 GLN A 196 MET A 413 MET A 131	ASC A 501 (-4.0A) None None None	1.39A	5u6mB-5zovA: undetectable	5u6mB-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5U6N_A_SALA505_1 (UDP-GLYCOSYLTRANSFER ASE 74F2)	5zov	- (-)	4 / 8	HIS A 194 GLN A 196 MET A 413 MET A 131	ASC A 501 (-4.0A) None None None	1.42A	5u6nA-5zovA: undetectable	5u6nA-5zovA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VW5_A_NCAA403_0 (FERREDOXIN--NADP REDUCTASE)	5zov	- (-)	4 / 8	THR A 45 GLY A 44 LEU A 294 ALA A 297	None	0.74A	5vw5A-5zovA: undetectable	5vw5A-5zovA: 21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZOV_A_ASCA501_0 (PTS ASCORBATE-SPECIFIC SUBUNIT IIBC)	5zov	- (-)	10 / 10	TYR A 87 HIS A 135 ILE A 136 GLN A 139 HIS A 194 GLN A 195 ARG A 288 ASP A 314 ALA A 316 ILE A 358	ASC A 501 (-4.0A) ASC A 501 (-4.0A) None ASC A 501 (-3.1A) ASC A 501 (-4.0A) ASC A 501 (-4.2A) ASC A 501 (-3.0A) ASC A 501 (-2.7A) ASC A 501 (-3.6A) ASC A 501 ( 4.9A)	0.01A	5zovA-5zovA: 74.7	5zovA-5zovA: undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5ZOV_B_ASCB501_0 (PTS ASCORBATE-SPECIFIC SUBUNIT IIBC)	5zov	- (-)	12 / 12	PRO A 86 TYR A 87 HIS A 135 ILE A 136 GLN A 139 HIS A 194 GLN A 195 ARG A 288 ASP A 314 ALA A 316 ILE A 358 MET A 415	None ASC A 501 (-4.0A) ASC A 501 (-4.0A) None ASC A 501 (-3.1A) ASC A 501 (-4.0A) ASC A 501 (-4.2A) ASC A 501 (-3.0A) ASC A 501 (-2.7A) ASC A 501 (-3.6A) ASC A 501 ( 4.9A) ASC A 501 ( 4.6A)	0.33A	5zovB-5zovA: 69.7	5zovB-5zovA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NM4_B_SAMB402_0 (HISTONE-LYSINE N-METHYLTRANSFERASE PRDM9)	5zov	- (-)	5 / 9	ILE A 399 ALA A 82 GLY A 81 LEU A 352 GLY A 356	None	1.03A	6nm4B-5zovA: undetectable	6nm4B-5zovA: undetectable

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1EI6_C_PPFC413_1","PHOSPHONOACETATE HYDROLASE","5zov","-","-",4,"ASP A 314;HIS A 194;HIS A 135;ILE A 358","ASC A 501 (-2.7A);ASC A 501 (-4.0A);ASC A 501 (-4.0A);ASC A 501 ( 4.9A)","0.98A","1ei6C-5zovA:undetectable","1ei6C-5zovA:undetectable"],["1QKN_A_RALA600_1","ESTROGEN RECEPTOR BETA","5zov","-","-",6,"LEU A 165;THR A 162;ALA A 163;LEU A 114;ILE A 172;GLY A 171","None","1.44A","1qknA-5zovA:undetectable","1qknA-5zovA:undetectable"],["1WRL_A_TFPA204_1","TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES;TROPONIN C, SLOW SKELETAL AND CARDIAC MUSCLES","5zov","-","-",4,"LEU A  62;PHE A 244;MET A 240;MET A 360","None","0.99A","1wrlA-5zovA:undetectable;1wrlB-5zovA:undetectable","1wrlA-5zovA:undetectable;1wrlB-5zovA:undetectable"],["2HMA_A_SAMA375_0","PROBABLE TRNA (5-METHYLAMINOMETHYL-2-THIOURIDYLATE)-METHYLTRANSFERASE","5zov","-","-",5,"SER A 295;THR A 133;GLY A 134;HIS A 135;GLN A 139","None;None;None;ASC A 501 (-4.0A);ASC A 501 (-3.1A)","1.45A","2hmaA-5zovA:undetectable","2hmaA-5zovA:undetectable"],["2WSC_A_PQNA1802_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1","5zov","-","-",5,"PHE A 347;SER A 349;ALA A 340;LEU A 343;GLY A 346","None","1.07A","2wscA-5zovA:3.6","2wscA-5zovA:undetectable"],["2WSE_A_PQNA1801_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1","5zov","-","-",5,"PHE A 347;SER A 349;ALA A 340;LEU A 343;GLY A 346","None","1.06A","2wseA-5zovA:2.6","2wseA-5zovA:undetectable"],["2WSF_A_PQNA1802_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1","5zov","-","-",5,"PHE A 347;SER A 349;ALA A 340;LEU A 343;GLY A 346","None","1.07A","2wsfA-5zovA:2.2","2wsfA-5zovA:undetectable"],["2X2N_A_X2NA1480_1","LANOSTEROL 14-ALPHA-DEMETHYLASE","5zov","-","-",5,"PHE A 370;PRO A 180;ALA A 183;ALA A 416;MET A 177","None","1.26A","2x2nA-5zovA:undetectable","2x2nA-5zovA:undetectable"],["2X2N_B_X2NB1479_1","LANOSTEROL 14-ALPHA-DEMETHYLASE","5zov","-","-",5,"PHE A 370;PRO A 180;ALA A 183;ALA A 416;MET A 177","None","1.27A","2x2nB-5zovA:undetectable","2x2nB-5zovA:undetectable"],["2X2N_C_X2NC1479_1","LANOSTEROL 14-ALPHA-DEMETHYLASE","5zov","-","-",5,"PHE A 370;PRO A 180;VAL A 184;ALA A 416;MET A 177","None","1.35A","2x2nC-5zovA:undetectable","2x2nC-5zovA:undetectable"],["3KO0_E_TFPE201_1","PROTEIN S100-A4;PROTEIN S100-A4","5zov","-","-",5,"PHE A  52;GLY A  51;PHE A 290;MET A  90;PHE A 138","None","1.34A","3ko0D-5zovA:undetectable;3ko0E-5zovA:0.8","3ko0D-5zovA:undetectable;3ko0E-5zovA:undetectable"],["3LW5_A_PQNA5001_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1","5zov","-","-",5,"PHE A 347;SER A 349;ALA A 340;LEU A 343;GLY A 346","None","1.08A","3lw5A-5zovA:3.5","3lw5A-5zovA:undetectable"],["4DJF_B_C2FB300_0","5-METHYLTETRAHYDROFOLATE CORRINOID\/IRON SULFUR PROTEIN METHYLTRANSFERASE","5zov","-","-",5,"PHE A 147;ILE A 353;LEU A 344;GLY A 394;GLN A 427","None","1.45A","4djfB-5zovA:undetectable","4djfB-5zovA:18.95"],["4EM2_A_SALA504_1","UNCHARACTERIZED HTH-TYPE TRANSCRIPTIONAL REGULATOR SAR2349","5zov","-","-",4,"GLY A 356;ILE A 358;ILE A 280;THR A  88","None;ASC A 501 ( 4.9A);None;None","0.48A","4em2A-5zovA:undetectable","4em2A-5zovA:undetectable"],["4JX1_F_CAMF502_0","CAMPHOR 5-MONOOXYGENASE","5zov","-","-",4,"TYR A  87;THR A 285;VAL A  55;ILE A 280","ASC A 501 (-4.0A);None;None;None","1.08A","4jx1F-5zovA:undetectable","4jx1F-5zovA:undetectable"],["4LNW_A_T3A502_1","THYROID HORMONE RECEPTOR ALPHA","5zov","-","-",4,"GLU A 391;GLN A 337;VAL A 239;THR A 236","None","0.88A","4lnwA-5zovA:undetectable","4lnwA-5zovA:undetectable"],["4LNX_A_T44A501_1","THYROID HORMONE RECEPTOR ALPHA","5zov","-","-",4,"GLU A 391;GLN A 337;VAL A 239;THR A 236","None","0.98A","4lnxA-5zovA:undetectable","4lnxA-5zovA:undetectable"],["4QVM_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","4qvmV-5zovA:undetectable;4qvmb-5zovA:undetectable","4qvmV-5zovA:undetectable;4qvmb-5zovA:undetectable"],["4QVM_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","4qvmH-5zovA:undetectable;4qvmN-5zovA:undetectable","4qvmH-5zovA:undetectable;4qvmN-5zovA:undetectable"],["4QVN_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","4qvnV-5zovA:undetectable;4qvnb-5zovA:undetectable","4qvnV-5zovA:undetectable;4qvnb-5zovA:undetectable"],["4QVN_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","4qvnH-5zovA:undetectable;4qvnN-5zovA:undetectable","4qvnH-5zovA:undetectable;4qvnN-5zovA:undetectable"],["4QVP_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","4qvpV-5zovA:undetectable;4qvpb-5zovA:undetectable","4qvpV-5zovA:undetectable;4qvpb-5zovA:undetectable"],["4QVP_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.24A","4qvpH-5zovA:undetectable;4qvpN-5zovA:undetectable","4qvpH-5zovA:undetectable;4qvpN-5zovA:undetectable"],["4QVQ_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","4qvqV-5zovA:undetectable;4qvqb-5zovA:undetectable","4qvqV-5zovA:undetectable;4qvqb-5zovA:undetectable"],["4QVQ_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","4qvqH-5zovA:undetectable;4qvqN-5zovA:undetectable","4qvqH-5zovA:undetectable;4qvqN-5zovA:undetectable"],["4QW0_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","4qw0V-5zovA:undetectable;4qw0b-5zovA:undetectable","4qw0V-5zovA:undetectable;4qw0b-5zovA:undetectable"],["4QW0_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","4qw0H-5zovA:undetectable;4qw0N-5zovA:undetectable","4qw0H-5zovA:undetectable;4qw0N-5zovA:undetectable"],["4QW3_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","4qw3V-5zovA:undetectable;4qw3b-5zovA:undetectable","4qw3V-5zovA:undetectable;4qw3b-5zovA:undetectable"],["4QW3_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","4qw3H-5zovA:undetectable;4qw3N-5zovA:undetectable","4qw3H-5zovA:undetectable;4qw3N-5zovA:undetectable"],["4RP8_A_ASCA501_0","ASCORBATE-SPECIFIC PERMEASE IIC COMPONENT ULAA","5zov","-","-",10,"TYR A  87;HIS A 135;ILE A 136;GLN A 139;HIS A 194;GLN A 195;ASP A 314;ALA A 316;PHE A 362;MET A 415","ASC A 501 (-4.0A);ASC A 501 (-4.0A);None;ASC A 501 (-3.1A);ASC A 501 (-4.0A);ASC A 501 (-4.2A);ASC A 501 (-2.7A);ASC A 501 (-3.6A);ASC A 501 (-3.8A);ASC A 501 ( 4.6A)","0.32A","4rp8A-5zovA:44.5","4rp8A-5zovA:undetectable"],["4RP8_C_ASCC501_0","ASCORBATE-SPECIFIC PERMEASE IIC COMPONENT ULAA","5zov","-","-",9,"HIS A 135;ILE A 136;GLN A 139;HIS A 194;GLN A 195;ALA A 316;ILE A 358;PHE A 362;MET A 415","ASC A 501 (-4.0A);None;ASC A 501 (-3.1A);ASC A 501 (-4.0A);ASC A 501 (-4.2A);ASC A 501 (-3.6A);ASC A 501 ( 4.9A);ASC A 501 (-3.8A);ASC A 501 ( 4.6A)","0.35A","4rp8C-5zovA:44.7","4rp8C-5zovA:62.88"],["4RP9_A_ASCA501_0","ASCORBATE-SPECIFIC PERMEASE IIC COMPONENT ULAA","5zov","-","-",11,"TYR A  87;HIS A 135;ILE A 136;GLN A 139;GLN A 195;ASP A 314;CYH A 315;ALA A 316;ILE A 358;PHE A 362;MET A 415","ASC A 501 (-4.0A);ASC A 501 (-4.0A);None;ASC A 501 (-3.1A);ASC A 501 (-4.2A);ASC A 501 (-2.7A);ASC A 501 ( 4.3A);ASC A 501 (-3.6A);ASC A 501 ( 4.9A);ASC A 501 (-3.8A);ASC A 501 ( 4.6A)","0.35A","4rp9A-5zovA:40.9","4rp9A-5zovA:62.88"],["5CZ7_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","5cz7H-5zovA:undetectable;5cz7N-5zovA:undetectable","5cz7H-5zovA:undetectable;5cz7N-5zovA:undetectable"],["5D0X_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","5d0xV-5zovA:undetectable;5d0xb-5zovA:undetectable","5d0xV-5zovA:undetectable;5d0xb-5zovA:undetectable"],["5D0X_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","5d0xH-5zovA:undetectable;5d0xN-5zovA:undetectable","5d0xH-5zovA:undetectable;5d0xN-5zovA:undetectable"],["5IK1_A_CAMA502_0","CAMPHOR 5-MONOOXYGENASE","5zov","-","-",4,"PHE A 385;LEU A 343;GLY A 342;ILE A 335","None","0.91A","5ik1A-5zovA:undetectable","5ik1A-5zovA:undetectable"],["5L5Z_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","5l5zV-5zovA:undetectable;5l5zb-5zovA:undetectable","5l5zV-5zovA:undetectable;5l5zb-5zovA:undetectable"],["5L5Z_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","5l5zH-5zovA:undetectable;5l5zN-5zovA:undetectable","5l5zH-5zovA:undetectable;5l5zN-5zovA:undetectable"],["5L66_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","5l66V-5zovA:undetectable;5l66b-5zovA:undetectable","5l66V-5zovA:undetectable;5l66b-5zovA:undetectable"],["5L66_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","5l66H-5zovA:undetectable;5l66N-5zovA:undetectable","5l66H-5zovA:undetectable;5l66N-5zovA:undetectable"],["5LF3_B_BO2B305_1","PROTEASOME SUBUNIT BETA TYPE-6","5zov","-","-",5,"THR A 408;THR A 407;GLY A 411;ALA A  92;THR A  88","None","1.25A","5lf3b-5zovA:undetectable","5lf3b-5zovA:undetectable"],["5NFP_A_8W5A804_2","GLUCOCORTICOID RECEPTOR","5zov","-","-",4,"LEU A 442;MET A 447;ILE A 425;LEU A 168","None","1.39A","5nfpA-5zovA:undetectable","5nfpA-5zovA:undetectable"],["5OG9_A_TESA504_1","-","5zov","-","-",5,"ILE A  84;VAL A 398;THR A  96;ALA A  92;THR A  93","None","1.32A","5og9A-5zovA:2.5","5og9A-5zovA:undetectable"],["5U6M_A_SALA503_1","UDP-GLYCOSYLTRANSFERASE 74F2","5zov","-","-",4,"HIS A 194;GLN A 196;MET A 413;MET A 131","ASC A 501 (-4.0A);None;None;None","1.47A","5u6mA-5zovA:undetectable","5u6mA-5zovA:undetectable"],["5U6M_B_SALB503_1","UDP-GLYCOSYLTRANSFERASE 74F2","5zov","-","-",4,"HIS A 194;GLN A 196;MET A 413;MET A 131","ASC A 501 (-4.0A);None;None;None","1.39A","5u6mB-5zovA:undetectable","5u6mB-5zovA:undetectable"],["5U6N_A_SALA505_1","UDP-GLYCOSYLTRANSFERASE 74F2","5zov","-","-",4,"HIS A 194;GLN A 196;MET A 413;MET A 131","ASC A 501 (-4.0A);None;None;None","1.42A","5u6nA-5zovA:undetectable","5u6nA-5zovA:undetectable"],["5VW5_A_NCAA403_0","FERREDOXIN--NADP REDUCTASE","5zov","-","-",4,"THR A  45;GLY A  44;LEU A 294;ALA A 297","None","0.74A","5vw5A-5zovA:undetectable","5vw5A-5zovA:21.71"],["5ZOV_A_ASCA501_0","PTS ASCORBATE-SPECIFIC SUBUNIT IIBC","5zov","-","-",10,"TYR A  87;HIS A 135;ILE A 136;GLN A 139;HIS A 194;GLN A 195;ARG A 288;ASP A 314;ALA A 316;ILE A 358","ASC A 501 (-4.0A);ASC A 501 (-4.0A);None;ASC A 501 (-3.1A);ASC A 501 (-4.0A);ASC A 501 (-4.2A);ASC A 501 (-3.0A);ASC A 501 (-2.7A);ASC A 501 (-3.6A);ASC A 501 ( 4.9A)","0.01A","5zovA-5zovA:74.7","5zovA-5zovA:undetectable"],["5ZOV_B_ASCB501_0","PTS ASCORBATE-SPECIFIC SUBUNIT IIBC","5zov","-","-",12,"PRO A  86;TYR A  87;HIS A 135;ILE A 136;GLN A 139;HIS A 194;GLN A 195;ARG A 288;ASP A 314;ALA A 316;ILE A 358;MET A 415","None;ASC A 501 (-4.0A);ASC A 501 (-4.0A);None;ASC A 501 (-3.1A);ASC A 501 (-4.0A);ASC A 501 (-4.2A);ASC A 501 (-3.0A);ASC A 501 (-2.7A);ASC A 501 (-3.6A);ASC A 501 ( 4.9A);ASC A 501 ( 4.6A)","0.33A","5zovB-5zovA:69.7","5zovB-5zovA:100.00"],["6NM4_B_SAMB402_0","HISTONE-LYSINE N-METHYLTRANSFERASE PRDM9","5zov","-","-",5,"ILE A 399;ALA A  82;GLY A  81;LEU A 352;GLY A 356","None","1.03A","6nm4B-5zovA:undetectable","6nm4B-5zovA:undetectable"]]